直 Japanese PDF Font
  • 我们的专业人员
  • 服务
  • 我们的见解
  • 办公室
  • 事务所
  • 人才招聘
Finnegan
  • Articles & Books
    • Ad Law Buzz Blog
    • At the PTAB Blog
    • European IP Blog
    • 联邦巡回法院知识产权博客
    • INCONTESTABLE® Blog
    • Prosecution First博客
  • Events & Webinars
  • 知识产权讯息
  • 播客
    • AI + Finnegan
    • AI + Copyright
    • AI + Patent
    • AI + Privacy
    • AI + Trade Secrets
    • AI + Trademark
  • Unified Patent Court (UPC) Hub

Laura P. Masurovsky

Jeff Totten on Track One Examination

November 12, 2012

By Jeffrey C. Totten

The new prioritized "Track One" examination, which is part of America Invents Act (AIA), offers companies the opportunity to "fast track" a patent for additional cost. The expedited review allows companies to be more competitive in the new first to file system and can shorten the wait time for USPTO review. Finnegan partner Jeffrey C. Totten discusses Track One examination and considerations for companies considering this new application track.

Downloadable Files

  • Totten_TrackOneExaminationPodcast_11-12-12

Related Practices

专利撰写与申办

Related Professionals

Jeffrey C. Totten
Partner
Washington, DC
+1 202 408 4232
Email

Related Insights

Conference

Atlantic Basin Conference on Chemistry 2026

December 6-9, 2026

Rio de Janeiro

Webinar

Data and Market Exclusivity: An Update on China’s New Law and Comparisons to the US and Europe

November 19, 2026

Webinar

Conference

4th Global Patent Litigation FORUM

October 29, 2026

Munich

Conference

2026 EDTX Bench Bar Conference

October 28-30, 2026

Fort Worth

Federal Circuit IP Blog

Federal Circuit Affirms Invalidity Challenge to Scientifically Impossible Claim Language on Enablement Grounds

October 23, 2026

Federal Circuit IP Blog

Federal Circuit Dismisses Non-Infringement Appeal of Only Certain Patent Claims, Denies Judge Reassignment

October 23, 2026

Articles

EPR Academy, Part 5 of 6: Special Considerations for Third-Party Requesters

October 14, 2026

Federal Circuit IP Blog

Private Sale Gets No Safe Harbor from §102(b)(1)(B)

October 14, 2026

Conference

2nd Annual Forum on Pharma & Biotech Patent Litigation USA & Canada

October 14-16, 2026

New York

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.

  • 隐私
  • 免责申明
  • Legal Notices
  • Fraud Alert
  • EEO Statement
  • Cookies
  • Contact Us

© 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP